• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. CARBOSEAL VALSALVA CONDUIT; CARBOSEAL VALSALVA SIZE 25 AORT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. CARBOSEAL VALSALVA CONDUIT; CARBOSEAL VALSALVA SIZE 25 AORT Back to Search Results
Model Number CP-025
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Date 11/10/2017
Event Type  Injury  
Event Description
Livanova was notified through a patient registration form that a cp-025 implanted in aortic position on (b)(6) 2014 has been explanted and a new cp-025 has been implanted.The reason of explant is still unknown.
 
Manufacturer Narrative
Based on the information provided in the event description, the event is attributable to patient factors and no device deficit is suspected.As such, no further investigation is required at this time.Device not returned.
 
Event Description
Manufacturer received additional information on 9-jan-2018: reason for explant of the device: "patient had a history of 3 previous root replacements.First for aortic aneurysm and then mechanical root for endocarditis, followed 6 weeks later by homograft.Patient had done well fro 2-3 years but 6 months ago had multiple infections and repeat imaging showed worsening mitral regurgitation and new pseudo aneurysm of the left main button and possible graft dehiscence.Patient had worsening chf from the mr and was hospitalized preoperatively for inotropic hemodynamic tailoring" note from operation report: "the previous homograft was exposed and completed excised.There appeared to be old healed vegetation on the left and non-homograft valve leaflets." patient outcome: patient was weaned from bypass - biventricular dysfunction - period of reperfusion on cpb and placement of iabp with tee guidance.Patient again weaned and was stable.Transported it icu in critical condition.Discharged (b)(6) 2016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOSEAL VALSALVA CONDUIT
Type of Device
CARBOSEAL VALSALVA SIZE 25 AORT
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key7149730
MDR Text Key95898012
Report Number3005687633-2017-00139
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P900060/S02
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 02/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date12/31/2016
Device Model NumberCP-025
Device Catalogue NumberCP-025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/28/2017
Initial Date FDA Received12/27/2017
Supplement Dates Manufacturer Received01/09/2018
02/16/2018
Supplement Dates FDA Received02/05/2018
02/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/19/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age38 YR
-
-